Delivery Order SPE2DB20D1100-SPE2DB25FB8Y3
- Not listed
- The Defense Logistics Agency awarded a $69,369.84 firm fixed-price delivery order to AmerisourceBergen Drug Corp for AVEED 750 mg/3 mL vials on September 2, 2025, with an ultimate completion date of September 23, 2025. This is a non-set-aside competitive award issued to the prime contractor's corporate office in Conshohocken, Pennsylvania. AVEED (testosterone undecanoate) is a long-acting testosterone replacement therapy used to treat hypogonadism, reflecting the DLA's ongoing commitment to...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $23,123.28 on August 7, 2025, for the supply of AVEED 750 mg/3 mL vials. This firm fixed-price delivery order, which has an ultimate completion date of August 28, 2025, represents a competitive award with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency awarded a delivery order valued at $44,319.62 to AmerisourceBergen Drug Corp for AVEED 750 mg/3 mL vials on August 7, 2025, with completion targeted for August 28, 2025. This firm fixed-price delivery order, which was not set aside for small business, represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's distribution center in...
- On January 13, 2026, the Defense Logistics Agency (DLA) awarded a delivery order valued at $24,368.64 to AmerisourceBergen Drug Corp for AVEED 750 MG/3 ML Vial 3ML, a testosterone replacement therapy medication. This firm fixed-price delivery order, with an ultimate completion date of February 4, 2026, was competitively awarded with no set-aside designation. The contract will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of AVEED 750 mg/3 mL vials. This firm fixed-price delivery order, valued at $6,092.16, is set to be completed by December 5, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting the company's demonstrated capability to meet federal...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on May 8, 2025, for the supply of AVEED 750 mg/3 mL vials. This firm fixed-price delivery order has a ceiling value of $96,347.00 and a completion date of May 30, 2025. The award was made through open competition with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania—which also serves as the place of performance—is a major...
- The Defense Logistics Agency Troop Support Medical awarded a $17,766 firm fixed price delivery order to Amerisourcebergen Drug Corporation for AVEED 750 MG/3 ML vials. The order is for 3ML vials of AVEED, a medication used to treat conditions such as hormone deficiency. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with delivery required between September 26 and October 18, 2023. The Defense Logistics Agency manages the Department of Defense's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for AVEED 750 mg/3 mL vials with a ceiling value of $9,634.70 under a firm fixed-price contract type. This order, which must be completed by November 18, 2025, represents a non-set-aside competitive award supporting federal medical procurement requirements. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor...
- The Defense Logistics Agency issued a $10,153.60 delivery order to Amerisourcebergen Drug Corp on April 27, 2026, for AVEED 750 mg/3 ml vial pharmaceutical supply with an ultimate completion date of May 18, 2026. Place of performance is Conshohocken, PA. The order is firm fixed price with no set-aside. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. and operates as a pharmaceutical distributor supplying brand-name and generic medications, specialty pharmaceuticals, and medical...
- The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 25, 2026, for AVEED 750 mg/3 ml vial with a ceiling value of $10,153.60 under firm fixed-price pricing. Place of performance is Conshohocken, PA. Ultimate completion date is March 18, 2026. The order was issued on a non-competitive basis. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor supplying federal medical procurement needs across DLA and other...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FB8Y3Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $19,269.40 to AmerisourceBergen Drug Corp for AVEED 750 mg/3 mL vials on April 23, 2025, with completion targeted for May 14, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. AVEED (testosterone undecanoate) is a prescription testosterone replacement therapy product, reflecting the company's ongoing role in supplying specialized pharmaceutical products to support military and federal healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated consistent capability to fulfill federal medical procurement requirements through competitive awards, positioning it as a critical vendor for the Defense Health Agency and other federal healthcare entities as the DLA plans future Pharmaceutical Prime Vendor Global Program Generation V contracts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.3k | 4/23/25 |